| Bioactivity | RAGE antagonist peptide TFA is an advanced glycation end products (RAGE) antagonist. RAGE antagonist peptide TFA prevents RAGE from binding with several of its most important ligands, including HMGB-1, S100P, and S100A4. RAGE antagonist peptide TFA possesses anti-tumor and anti-inflammatory activities[1][2]. | ||||||
| Invitro | RAGE antagonist peptide TFA (RAP) reduces the ability of the ligands to stimulate RAGE activation of NFκB in cancer cells in vitro[1]. | ||||||
| Name | RAGE antagonist peptide TFA | ||||||
| Shortening | Ac-ELKVLMEKEL-NH2 | ||||||
| Formula | C59H102F3N13O19S | ||||||
| Molar Mass | 1386.58 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
RAGE antagonist peptide TFA
CAS: F: C59H102F3N13O19S W: 1386.58
RAGE antagonist peptide TFA is an advanced glycation end products (RAGE) antagonist. RAGE antagonist peptide TFA prevent
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.